FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncology. Diagnosis of a malignant growth requires conducting cytological preparation analysis by atomic force microscopy (AFM). The AFM involves measuring vertical dimensions of cell elements and regulating these dimensions. The characteristic functions of the regulated dimensions of the measured cell elements are evaluated. An affinity criterion of the evaluated characteristic functions to their reference values specified in accordance with any given disease, including malignancies is used to diagnose or exclude a malignant growth.
EFFECT: method provides higher diagnostic reliability in the malignant growth ensured by objectification of cytological data, higher measurement accuracy and reproducibility.
2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF FIBROADENOMA AND BREAST CANCER | 2020 |
|
RU2730993C2 |
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF THYROID CARCINOMA | 2011 |
|
RU2485517C2 |
| CANCER DIAGNOSTIC METHOD | 2006 |
|
RU2306868C1 |
| METHOD OF PRODUCING CELL BLOCKS FOR CYTOLOGICAL AND IMMUNOCYTOCHEMICAL DIAGNOSIS OF MALIGNANT NEOPLASMS | 2023 |
|
RU2818060C1 |
| METHOD FOR EMERGENCY FLUORESCENT DIFFERENTIAL IMMUNOCYTOCHEMICAL DIAGNOSIS OF CANCER METASTASES IN LYMPH NODES AND NON-HODGKIN LYMPHOMA | 2015 |
|
RU2580612C2 |
| METHOD FOR SCREENING DIFFERENTIAL DIAGNOSIS OF PRECANCEROUS DISEASES AND CANCER OF THE ORAL MUCOSA (OM) | 2021 |
|
RU2754295C1 |
| METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND | 2022 |
|
RU2805941C1 |
| URGENT FLUORESCENT IMMUNOCYTOCHEMICAL DIAGNOSIS OF METASTATIC LYMPH NODE | 2014 |
|
RU2582275C1 |
| METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULAR FORMATIONS OF THE THYROID GLAND | 2021 |
|
RU2783304C1 |
| METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
